戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                                 Periostin, a matricellular adapter protein highly expressed by period
2 d and uninfected devices, and these included matricellular and inflammatory proteins.
3                                          The matricellular angiogenesis inhibitor, thrombospondin (TS
4                           Mice that lack the matricellular angiogenesis inhibitor, thrombospondin-2 (
5 GF and NOV) family of proteins is a group of matricellular biomolecules involved in both physiologica
6 lting from cardiomyocyte-TrkA recognition by matricellular connective tissue growth factor (CTGF/CCN2
7     These included several proteoglycans and matricellular ECM proteins composed of common repetitive
8 epithelial STAT3 activity and develop stiff, matricellular-enriched fibrosis associated with high epi
9 ing promotes tumor progression by increasing matricellular fibrosis and tissue tension.
10 he findings implicate epithelial tension and matricellular fibrosis in the aggressiveness of SMAD4 mu
11 r lesion formation, we examined whether this matricellular gene cluster was also coordinately regulat
12         Human thrombospondin 1 (hTSP-1) is a matricellular glycoprotein facilitating bacterial adhere
13 f angiogenesis is thrombospondin-1 (TSP1), a matricellular glycoprotein known to influence adhesion,
14                                          The matricellular glycoprotein SPARC (secreted protein acidi
15                                          The matricellular glycoprotein SPARC (secreted protein acidi
16 e (SPARC) is an extracellular Ca(2+)-binding matricellular glycoprotein that associates with cell pop
17 in, acidic and rich in cysteine (SPARC) is a matricellular glycoprotein that is capable of inhibiting
18 d Protein Acidic and Rich in Cysteine), is a matricellular glycoprotein that is produced by tumor and
19                                    The human matricellular glycoprotein thrombospondin-1 (hTSP-1) is
20 hibition of some angiogenic responses by the matricellular glycoprotein thrombospondin-1 and is there
21 e necessary for some T cell responses to the matricellular glycoprotein thrombospondin-1.
22                        Tenascin C (TNC) is a matricellular glycoprotein whose expression in adult tis
23                  Thrombospondin (TSP)-1 is a matricellular glycoprotein with immunoregulatory propert
24 at SPARC/osteonectin, a small ECM-associated matricellular glycoprotein, can induce MMP-2 activation
25 tential role for thrombospondin-2 (TSP-2), a matricellular glycoprotein, in the regulation of primary
26                              SPARC, a 32-kDa matricellular glycoprotein, mediates interactions betwee
27 ted protein, acidic and rich in cysteine), a matricellular glycoprotein, modulates the interaction of
28 ich in cysteine (SPARC) is a multifunctional matricellular glycoprotein.
29 interaction of Streptococcus pneumoniae with matricellular hTSP-1.
30                            CCN1 (CYR61) is a matricellular inducer of angiogenesis essential for succ
31 ed as a cell scaffold to study the effect of matricellular interactions in vitro.
32 ealing in skin fibroblasts and establish its matricellular mode of action through integrin receptors.
33 uch as CCN1, an immediate-early gene-encoded matricellular molecule critical for vascular development
34             CCN6 is a secreted cysteine-rich matricellular protein (36.9 kDa) that exerts growth-inhi
35 ficantly, we found that the TGF-beta-induced matricellular protein (TGFBI) was similarly biphasically
36                                    CCN1 is a matricellular protein and a member of the CCN family of
37             In PDAC patient biopsies, higher matricellular protein and activated STAT3 were associate
38 ed, cooperative interaction between the CCN1 matricellular protein and canonical TGF-beta1/SMAD3 sign
39                                   Hevin is a matricellular protein and the result of a gene duplicati
40 ed protein acidic and rich in cysteine) is a matricellular protein associated with the extracellular
41             Previous studies showed that the matricellular protein CCN1 (CYR61) is induced during hep
42                                          The matricellular protein CCN1 (CYR61) regulates multiple ce
43                                          The matricellular protein CCN1 (formerly named CYR61) regula
44                                          The matricellular protein CCN1 enhances TGF-beta1/SMAD3-depe
45                        Here we show that the matricellular protein CCN1/CYR61 can unmask the cytotoxi
46 titative mass spectrometry, we find that the matricellular protein CCN1/CYR61 is highly regulated by
47 ecently provided the first evidence that the matricellular protein CCN3 (official symbol NOV) functio
48 re, we determined that the expression of the matricellular protein CCN3 is strongly reduced in rodent
49 ght to interact with BMP-2: collagen IIA and matricellular protein CCN3.
50                                          The matricellular protein CCN5/WISP-2 represents a promising
51                                          The matricellular protein connective tissue growth factor (C
52                 Thrombospondin 2 (TSP2) is a matricellular protein controlling the apoptosis-prolifer
53 cytes with keratinocytes upregulates CCN3, a matricellular protein critical to maintenance of normal
54 everal microarray databases suggest that the matricellular protein Cyr61 is highly induced by LPA.
55 tion by these agonists and revealed that the matricellular protein cysteine-rich 61 (Cyr61/CCN1) is s
56 lammatory mediator cyclooxygenase 2, and the matricellular protein cysteine-rich angiogenic inducer 6
57                               Periostin is a matricellular protein essential for tissue integrity and
58 duction by reporting a novel function of the matricellular protein Fibulin-5 (Fbln5).
59 vel downstream target Sparc, which encodes a matricellular protein found in PDAC stroma that has been
60 ervations suggest an important role for this matricellular protein in the local regulation of inflamm
61                                    CCN1 is a matricellular protein involved in normal vascular develo
62      Previously, we showed that periostin, a matricellular protein involved in tissue repair, is mark
63 th factor (CTGF) is a cysteine-rich secreted matricellular protein involved in wound healing and tiss
64 bospondin-1 (TSP) is a transiently expressed matricellular protein known to promote chemotaxis of leu
65 Thrombospondin-1 (TSP1) is a multifunctional matricellular protein known to promote progression of ch
66 ein acidic and rich in cysteine (SPARC) is a matricellular protein known to regulate extracellular ma
67                         Here we identify the matricellular protein Nephroblastoma Overexpressed (Nov,
68   Here we show that CCN6 (WISP3), a secreted matricellular protein of the CCN (CYR61/CTGF/NOV) family
69                    Here we show that CCN1, a matricellular protein of the CCN (CYR61/CTGF/NOV) family
70 r CCN1 (cysteine-rich 61, CYR61), a secreted matricellular protein of the CCN family, is a ligand of
71 CN3 (NOV, nephroblastoma overexpressed) is a matricellular protein of the CCN family, which also incl
72                              CCN3 (NOV) is a matricellular protein of the CCN family, which also incl
73                 Cysteine-rich 61 (CCN1) is a matricellular protein of which expression is up-regulate
74                                   SPARC is a matricellular protein often associated with fibrosis.
75                                          The matricellular protein osteopontin (OPN, Spp-1) is widely
76  are the first to show that induction of the matricellular protein osteopontin facilitates DMBA/TPA-i
77 hat Wnt-1 strongly induced the expression of matricellular protein osteopontin, and modestly enhanced
78 cretion of profibrotic proteins, such as the matricellular protein periostin.
79                       Periostin (Postn) is a matricellular protein preferentially expressed by osteoc
80  Connective tissue growth factor (CTGF) is a matricellular protein presumed to be involved in the pat
81 ers of fibrinolysis, endothelial activation, matricellular protein release, and tissue damage and wit
82 , fibrinolysis, endothelial cell activation, matricellular protein release, and tissue damage were me
83 ered the role of thrombospondin-1 (TSP-1), a matricellular protein released in abundance from activat
84 otein 61 (Cyr61) is a dynamically expressed, matricellular protein required for proper angiogenesis a
85  secreted cysteine-rich and integrin-binding matricellular protein required for proper cardiovascular
86                                          The matricellular protein secreted protein acidic and rich i
87 le of which was the evolutionarily conserved matricellular protein Secreted Protein Acidic and Rich i
88 and rich in cysteine)/BM 40/osteonectin is a matricellular protein shown to function as a counteradhe
89                                          The matricellular protein SMOC (Secreted Modular Calcium bin
90 r-activation of the small GTPase Ran and the matricellular protein SMOC-2 that has important conseque
91 Arntl2 partner and functionally validate the matricellular protein Smoc2 as a pro-metastatic secreted
92                                          The matricellular protein SPARC (secreted protein acidic and
93  observed in the presence and absence of the matricellular protein SPARC (secreted protein, acidic an
94    This study identifies the stromal-derived matricellular protein SPARC as a novel regulator of isle
95                             We show that the matricellular protein SPARC contributes to the BM stroma
96                                          The matricellular protein SPARC is expressed at high levels
97                        The gene encoding the matricellular protein SPARCL1 was most strongly upregula
98  In addition, interstitial deposition of the matricellular protein tenascin, a marker of active remod
99                                     SPARC, a matricellular protein that affects cellular adhesion and
100 rowth factor (CCN2, also known as CTGF) is a matricellular protein that appears to play an important
101                       Fibulin-5 (Fbln5) is a matricellular protein that blocks fibronectin-integrin i
102   We show that CCN1 (also known as CYR61), a matricellular protein that dampens and resolves liver fi
103                 Thrombospondin-1 (TSP1) is a matricellular protein that differentially promotes the a
104                 Thrombospondin-1 (TSP1) is a matricellular protein that displays both pro- and anti-a
105                                    CCN1 is a matricellular protein that has been implicated in angiog
106                Thrombospondin 1 (TSP-1) is a matricellular protein that inhibits angiogenesis and cau
107 d Protein, Acidic and Rich in Cysteine) is a matricellular protein that inhibits mesangial cell proli
108 reported that fibulin-5, an integrin-binding matricellular protein that is essential for elastic fibe
109                            CCN1 (CYR61) is a matricellular protein that is highly expressed at sites
110                                   SPARC is a matricellular protein that is highly expressed in remode
111 ed connective tissue growth factor (CTGF), a matricellular protein that is highly expressed in the br
112 ein acidic and rich in cysteine (SPARC) is a matricellular protein that is important for the regulati
113                                   SPARC is a matricellular protein that is involved in both pancreati
114  Connective tissue growth factor (CCN2) is a matricellular protein that is up-regulated in many fibro
115  Connective tissue growth factor (CTGF) is a matricellular protein that mediates cell-matrix interact
116 d protein, acidic and rich in cysteine) is a matricellular protein that modulates cell adhesion and p
117 protein acidic rich in cysteine (SPARC) is a matricellular protein that modulates the activity of gro
118  (osteonectin) (SPARC) gene, which encodes a matricellular protein that participates in normal tissue
119 ue growth factor (CTGF/CCN2) is an inducible matricellular protein that plays a major role in fibropr
120 ytes with keratinocytes up-regulated CCN3, a matricellular protein that we subsequently found to be c
121                                          The matricellular protein thrombospondin (TSP) stimulates st
122 to test the hypothesis that the prototypical matricellular protein thrombospondin (TSP)-1, a potent a
123                     We hypothesized that the matricellular protein thrombospondin (TSP)-1, a potent i
124                                          The matricellular protein thrombospondin 1 (TSP1) regulates
125                                          The matricellular protein thrombospondin 2 (TSP2) regulates
126            We tested the hypothesis that the matricellular protein thrombospondin-1 (TSP1), through b
127              We reported previously that the matricellular protein thrombospondin-1 is upregulated in
128                        Because levels of the matricellular protein thrombospondin-4 (TSP4) rapidly ri
129 ng Protein-2 (Smoc-2) is a broadly-expressed matricellular protein which contributes to mitogenesis v
130                   We recently noted that the matricellular protein WISP1 contributes to sepsis induce
131       Tenascin-C (TNC) is a highly conserved matricellular protein with a distinct expression pattern
132                   Thrombospondin 2 (TSP2), a matricellular protein with a primary role in modulating
133 otein acidic and rich in cysteine (SPARC), a matricellular protein with counteradhesive properties, i
134              Periostin is considered to be a matricellular protein with expression typically confined
135                       Osteopontin (OPN) is a matricellular protein with proinflammatory and profibrot
136                               Periostin is a matricellular protein with roles in tissue repair follow
137 bospondin-1 (TSP-1), a potent proatherogenic matricellular protein, as a putative link between hyperg
138                                          The matricellular protein, connective tissue growth factor (
139 , acidic and rich in cysteine (SPARC) family matricellular protein, during invasive phases of prostat
140 ests that CYR61 (now named CCN1), a secreted matricellular protein, has a role in the pathogenesis of
141 ne), although primarily known as a secreted, matricellular protein, has also been identified in uroth
142                                 Periostin, a matricellular protein, has an important role during reep
143    Periostin (PN), a novel fasciclin-related matricellular protein, has been implicated in cardiac de
144                                          The matricellular protein, thrombospondin-1 (TSP-1), is prom
145                                          The matricellular protein, thrombospondin-2 (TSP-2), has bee
146 lved in extracellular matrix remodeling, and matricellular protein-protein and protein-cholangiocarci
147  and rich in cysteine), or osteonectin, is a matricellular protein.
148 e CCN family of proteins, is a cysteine-rich matricellular protein.
149 ster analysis, we identified a subset of six matricellular proteins (eg, osteopontin and plasminogen
150  small leucin-rich repeat proteoglycans, and matricellular proteins affecting both the composition an
151 lecular signature composed of an ensemble of matricellular proteins and remodeling enzymes they provi
152                                   Given that matricellular proteins are expressed in response to inju
153                                              Matricellular proteins are extracellular matrix proteins
154                                              Matricellular proteins are induced in fibrotic condition
155                                    The three matricellular proteins considered here might each prefer
156                      Furthermore, a role for matricellular proteins in the regulation skin blood flow
157                                              Matricellular proteins mediate pleiotropic effects durin
158                                Deposition of matricellular proteins modulates growth factor signaling
159 y, we demonstrate that the presence of these matricellular proteins results in significantly stiffer
160                                              Matricellular proteins such as SPARC, thrombospondin 1 a
161             They comprise a diverse group of matricellular proteins that confer antiadhesive properti
162 e 1 (SC1) is a member of the SPARC family of matricellular proteins that has been implicated in the r
163         Thrombospondin-1 (TSP1) and TSP2 are matricellular proteins that have been shown to regulate
164 1) is a member of the CCN family of secreted matricellular proteins that includes connective tissue g
165 -adhesion is induced by the highly regulated matricellular proteins TSP1 and 2, tenascin-C, and SPARC
166 e we show that CCN1 (CYR61) and CCN2 (CTGF), matricellular proteins upregulated at sites of inflammat
167 ediators of extracellular matrix remodeling, matricellular proteins, and cardiac integrins compared w
168 d SPARC, two homologs of the SPARC family of matricellular proteins, in the foreign body response.
169 ndly decreased gene expression of a group of matricellular proteins, of which periostin was prominent
170                                              Matricellular proteins, secreted macromolecules that int
171                                Whereas major matricellular proteins, such as osteopontin, tenascin or
172 C-2 is a novel member of the SPARC family of matricellular proteins.
173 otensin axis, matrix metalloproteinases, and matricellular proteins.
174 ysiologic significance of this action of the matricellular proteins?
175 rograms and circulating osteopontin (OPN), a matricellular regulator of arteriosclerosis.
176                                          The matricellular secreted protein connective tissue growth
177                                              Matricellular Secreted Protein, Acidic and Rich in Cyste
178 Ab) that is directed against the pleiotropic matricellular signaling protein connective tissue growth
179                                          The matricellular SPARC family member hevin (SPARC-like 1/SP
180 r to the classical PspC molecule, with human matricellular thrombospondin-1 (hTSP-1).

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top